Post-COVID Asthma & Long COVID Breathing Problems

Q: Can COVID-19 cause asthma in someone who never had it before?

Yes. Research shows that approximately 13% of COVID-19 survivors develop new-onset asthma within 12 months of infection, compared to 5.5% of matched controls. SARS-CoV-2 causes direct bronchial epithelial injury, mast cell activation, and persistent airway hyperresponsiveness — all of which can trigger asthma in susceptible individuals who never had it before. This is a recognized complication of COVID-19 and should be formally evaluated with lung function testing.

Q: How long can COVID breathing problems last?

Long COVID respiratory symptoms — including shortness of breath, persistent cough, and chest tightness — can persist for months to years. Studies show that 30-40% of COVID-19 survivors report breathing difficulties at 12 months post-infection. In some individuals, symptoms reflect structural airway changes; in others, they reflect deconditioning, dysfunctional breathing, or PASC-related autonomic dysfunction. A pulmonologist can determine which mechanism applies and tailor treatment accordingly.

Q: How do I know if my long COVID symptoms are actually asthma?

Asthma-specific features include: symptoms that vary day-to-day, worsen at night, respond to bronchodilators (albuterol), or are triggered by exercise, cold air, or allergens. Spirometry showing reversible airflow obstruction (FEV1 improvement 12% and 200 mL after bronchodilator) confirms asthma. A methacholine challenge test can identify bronchial hyperresponsiveness when spirometry is normal. Elevated fractional exhaled nitric oxide (FeNO 25 ppb) suggests eosinophilic airway inflammation. A pulmonologist can order and interpret these tests.

Q: What is the difference between long COVID and asthma?

Long COVID (PASC) is a broad syndrome with 200+ reported symptoms spanning multiple organ systems. Respiratory long COVID can include dyspnea from deconditioning, dysfunctional breathing patterns, POTS, vocal cord dysfunction, organizing pneumonia — or genuine new-onset asthma. Asthma is specifically a chronic inflammatory airway disease with bronchial hyperresponsiveness and variable airflow obstruction. The two conditions can coexist. Proper lung function testing differentiates them.

Q: Can a COVID vaccine or booster trigger asthma symptoms?

Rarely. Some individuals with pre-existing asthma report transient worsening of symptoms after COVID vaccination, which typically resolves within 24-48 hours. People with asthma, including severe asthma, are generally encouraged to receive COVID vaccines, as COVID-19 itself carries far greater risk of asthma exacerbation or respiratory failure than the vaccine. Consult your physician before vaccination if you have concerns.

Q: What treatments exist for post-COVID asthma?

Post-COVID asthma responds to standard asthma treatments: inhaled corticosteroids (ICS) are the cornerstone therapy, combined with long-acting beta-agonists (LABA) when needed. For eosinophilic disease with high FeNO, biologic therapies (dupilumab, mepolizumab, benralizumab) offer significant benefit. Associated PASC components — dysfunctional breathing, deconditioning, anxiety-related dyspnea — require breathing retraining, graded exercise rehabilitation, and sometimes psychological support. Consult your physician for a personalized plan.

Q: When should I see a pulmonologist for post-COVID breathing problems?

See a pulmonologist if: you still have shortness of breath, cough, or wheeze more than 4 weeks after COVID-19; your primary care physician has not been able to explain or relieve your symptoms; your breathing limits daily activity or exercise; you suspect asthma but have not had formal lung function testing; or you are using a rescue inhaler more than twice per week. In Plantation, FL and greater Broward County, Dr. Frank Hull at Advanced Asthma Clinic specializes in post-COVID pulmonary evaluation. Call 954-522-7226.

For millions of Americans who recovered from COVID-19, the illness did not simply end. Shortness of breath at the grocery store. A cough that will not quit months later. Chest tightness that appears out of nowhere. These lingering respiratory symptoms are among the most common complaints in what researchers now call Post-Acute Sequelae of SARS-CoV-2 (PASC) — more widely known as Long COVID.

What many patients and even some clinicians do not realize is that COVID-19 can cause new-onset asthma in people who never had it before — and it can severely destabilize pre-existing asthma, sometimes permanently shifting a person's disease trajectory. Distinguishing genuine new-onset asthma from the many other causes of post-COVID breathlessness requires formal lung function testing, not just symptom history.

At Advanced Asthma Clinic in Plantation, FL, Dr. Frank Hull brings 20+ years of pulmonary research experience to evaluating patients with post-COVID respiratory complications across Broward County and South Florida.

Key Distinction

The existing page Asthma & COVID-19 covers acute-phase risk — how COVID affects people who already have asthma during active infection. This article addresses what happens after COVID-19 resolves: new-onset asthma, PASC respiratory sequelae, and long COVID breathing complications.

~13%

COVID survivors develop new-onset asthma within 12 months

30–40%

Report breathing difficulties at 12 months post-COVID

200+

Documented Long COVID symptoms across organ systems

2×

Increased asthma incidence vs. matched COVID-negative controls

How COVID-19 Damages the Airways

SARS-CoV-2 binds to ACE2 receptors, which are densely expressed in bronchial epithelial cells. This creates a cascade of airway injury that can persist long after the virus itself is cleared.

COVID-19 Airway Injury — Step-by-Step Mechanism

SARS-CoV-2 binds ACE2 receptors on bronchial epithelium. Direct viral cytotoxicity damages the mucociliary escalator — the airway's primary defense mechanism.

Cytokine storm triggers Type 2 airway inflammation. IL-4, IL-5, IL-13, and IL-33 drive eosinophil recruitment and mast cell degranulation — the same inflammatory pathways active in allergic asthma.

Bronchial hyperresponsiveness (BHR) develops. Damaged epithelium exposes sensory nerve endings. Airway smooth muscle becomes hypersensitive to stimuli — cold air, exercise, allergens, strong odors.

Mucus gland hypertrophy and goblet cell metaplasia. Chronic inflammatory signaling causes structural airway remodeling, increasing mucus production and airway wall thickness.

Persistent airway inflammation without ongoing infection. In susceptible individuals, the inflammatory cascade becomes self-sustaining — meeting the physiological definition of asthma, even when COVID-19 PCR is long-negative.

Beyond direct airway damage, COVID-19 also triggers changes in the autonomic nervous system, which can cause exaggerated bronchoconstriction through increased parasympathetic tone — another pathway to bronchospasm and breathlessness even without eosinophilic inflammation.

New-Onset Asthma After COVID-19: What the Evidence Shows

Multiple large epidemiological studies have confirmed what pulmonologists were observing clinically: COVID-19 substantially increases the risk of developing asthma for the first time.

A 2022 analysis of more than 40,000 COVID-19 survivors found that new-onset asthma occurred at approximately twice the rate in COVID-19 patients compared to COVID-19-negative controls over 12 months follow-up. The risk was highest among patients who had been hospitalized, but was also significantly elevated in those with mild outpatient disease.

Who Is Most at Risk?

History of allergic disease — atopic dermatitis, hay fever, food allergy: COVID may unmask a latent asthma diathesis
Childhood respiratory infections — prior RSV or rhinovirus-induced wheeze increases susceptibility
Female sex — women demonstrate higher rates of new-onset post-COVID asthma across multiple studies
Severity of acute illness — hospitalization, ICU admission, and oxygen requirement correlate with higher risk
Smoking history — current or former smokers face compounded airway vulnerability
Obesity (BMI ≥30) — promotes systemic inflammation that amplifies COVID-induced airway injury

Important

New-onset post-COVID asthma cannot be diagnosed based on symptoms alone. Many conditions cause breathlessness, cough, and chest tightness after COVID-19 — and each requires different treatment. Formal spirometry and, where indicated, additional lung function testing is essential before starting asthma therapy.

Distinguishing Post-COVID Asthma from Other Causes of Breathlessness

This is the most critical clinical challenge in post-COVID respiratory care. The symptom overlap among different conditions is substantial, yet the treatments diverge significantly. Giving an asthma inhaler to someone with dysfunctional breathing or POTS — while missing the actual diagnosis — delays recovery.

Feature	New-Onset Asthma	PASC Dysfunctional Breathing	Vocal Cord Dysfunction	Deconditioning
Timing	Persistent, episodic	Continuous or effort-related	Episodic, sudden onset	Only with exertion
Wheeze	Expiratory wheeze common	None or variable	Inspiratory stridor	None
Response to albuterol	Yes — significant improvement	Partial or none	Minimal	None
Spirometry	Obstructive pattern, reversible	Often normal	Flattened inspiratory loop	Normal
Night symptoms	Common (classic asthma feature)	Less common	Rare	No
FeNO	Often elevated (>25 ppb)	Normal	Normal	Normal
Primary treatment	ICS ± LABA, biologics	Breathing retraining, physiotherapy	Speech therapy, laryngoscopy	Graded exercise rehabilitation

Other Conditions to Rule Out

Organizing pneumonia (OP): Post-COVID inflammatory consolidation requiring oral corticosteroids, not inhalers
Pulmonary fibrosis: Restrictive pattern on spirometry; high-resolution CT essential
POTS (postural orthostatic tachycardia syndrome): Tachycardia-driven dyspnea requiring tilt-table testing
Pulmonary embolism: Must be excluded early in patients with persistent exertional dyspnea
Heart failure: COVID-19-associated myocarditis can reduce cardiac output, mimicking respiratory symptoms
Anxiety and panic disorder: Amplified breathlessness perception; genuine PASC component but not primary pulmonary pathology

Diagnosis: Lung Function Testing for Post-COVID Asthma

At Advanced Asthma Clinic in Plantation, FL, Dr. Frank Hull employs a structured diagnostic approach for patients presenting with post-COVID respiratory symptoms. Comprehensive lung function testing is the cornerstone of accurate diagnosis.

1

Spirometry with Bronchodilator Reversibility
Measures FEV1 (forced expiratory volume in 1 second) and FVC (forced vital capacity). A post-bronchodilator FEV1 improvement ≥12% and ≥200 mL confirms reversible airflow obstruction — the hallmark of asthma. A normal result does not rule out asthma.
2

Fractional Exhaled Nitric Oxide (FeNO)
A breath test measuring airway eosinophilic inflammation. FeNO ≥25 ppb (intermediate) or ≥50 ppb (high) strongly suggests Type 2 airway inflammation responsive to inhaled corticosteroids and biologic therapy. Low FeNO (<25 ppb) with normal spirometry redirects toward non-asthma diagnoses.
3

Methacholine Challenge Test
When spirometry is normal but asthma is still suspected, inhaled methacholine provokes bronchoconstriction. A PC20 <4 mg/mL indicates marked bronchial hyperresponsiveness consistent with asthma. This test has a very high negative predictive value — a negative result makes asthma unlikely.
4

Full Pulmonary Function Tests (PFTs) with DLCO
Complete PFTs including lung volumes (TLC, RV) and diffusion capacity (DLCO) detect restrictive patterns from fibrosis or diffusion defects from vascular disease or parenchymal damage — findings that require different investigation than asthma.
5

Cardiopulmonary Exercise Testing (CPET)
In complex cases, CPET identifies the limiting system driving exertional dyspnea: cardiac, pulmonary, deconditioning, or peripheral. Especially valuable in post-COVID patients where multiple mechanisms coexist.
6

Laryngoscopy (if VCD suspected)
Visualization of vocal cord movement during breathing. Vocal cord dysfunction (inducible laryngeal obstruction, ILO) is substantially more common post-COVID than previously recognized, and is frequently misdiagnosed as poorly controlled asthma.

Treatment of Post-COVID Asthma

Once post-COVID asthma is confirmed, treatment follows the same evidence-based framework as classic asthma — with important nuances related to the post-COVID inflammatory milieu.

Step 1: Inhaled Corticosteroids (ICS)

Cornerstone first-line therapy
Reduce eosinophilic airway inflammation
Examples: fluticasone, budesonide, beclomethasone
Begin at low-medium dose; titrate based on FeNO response
Takes 4–8 weeks for full anti-inflammatory effect

Step 2: ICS + LABA Combination

Added when ICS alone is insufficient
LABA (salmeterol, formoterol) provides 12-hour bronchodilation
Examples: Symbicort, Advair, Breo Ellipta
LABA must always be paired with ICS — never as monotherapy
SMART therapy reduces exacerbations in moderate-severe disease

Step 3: Leukotriene Modifiers

Montelukast (Singulair) targets leukotriene-driven inflammation
Useful in post-COVID asthma with allergic or AERD component
Black box warning: neuropsychiatric side effects — review with physician
Zileuton (Zyflo) for aspirin-exacerbated respiratory disease

Step 4: Biologic Therapy

Indicated for severe, eosinophilic, or Type 2-high post-COVID asthma
Dupilumab (Dupixent): targets IL-4/IL-13; also addresses PASC Type 2 systemic inflammation
Mepolizumab (Nucala), benralizumab (Fasenra): anti-IL-5 for eosinophilic disease
Tezepelumab (Tezspire): broadest mechanism; reduces all exacerbation types
Learn more about biologic therapy

Treating Non-Asthma PASC Components

Dysfunctional breathing: Buteyko technique, physiotherapy breathing retraining
Deconditioning: Structured graded exercise rehabilitation (pacing critical)
VCD: Speech-language therapy, laryngeal control exercises
POTS: Fluid/salt loading, compression garments, beta-blockers
Anxiety: Cognitive behavioral therapy; pulmonary rehabilitation

Monitoring & Follow-Up

Repeat spirometry at 3 months on therapy
FeNO monitoring guides ICS dose titration
Asthma Control Test (ACT) at each visit
Peak flow diary between appointments
Annual PFT in severe or complex disease
Reassess biologic response at 4 months

Long COVID Cough: A Special Category

Chronic cough is one of the most debilitating long COVID symptoms, affecting up to 25% of COVID-19 survivors at 3 months and approximately 15% at 12 months. While asthma-related cough (cough-variant asthma) is one cause, post-COVID cough syndrome often involves multiple overlapping mechanisms:

Cough hypersensitivity syndrome: COVID-19 upregulates TRPV1 and P2X3 cough receptor expression in airway sensory nerves, producing a hair-trigger cough reflex. P2X3 antagonist therapy is under active investigation in clinical trials.
Post-nasal drip: Sinonasal inflammation after COVID drives chronic cough; nasal endoscopy and sinonasal CT help diagnose this component.
Gastroesophageal reflux (GERD): COVID-related autonomic dysfunction can worsen gastric emptying and increase reflux — a major cough trigger.
Cough-variant asthma: Chronic cough as the only asthma symptom, diagnosed by positive methacholine challenge and response to ICS.
Upper airway cough syndrome (UACS): Responds to antihistamines and intranasal corticosteroids.

Clinical Trial Opportunity

Lung Research Florida (954-520-7296 x1), affiliated with Advanced Asthma Clinic, is actively recruiting participants for a clinical trial investigating a novel P2X3 antagonist for chronic cough. Patients with long COVID cough lasting more than 8 weeks who have not responded to standard treatments may be eligible. Visit lungresearchflorida.com for details.

Post-COVID Asthma in Broward County: Local Context

South Florida's climate — high humidity, year-round elevated allergen burden, Saharan dust events, and subtropical air quality variability — creates an environment that challenges post-COVID airways more than most U.S. regions. Patients in Plantation, Fort Lauderdale, Davie, Pembroke Pines, Miramar, and surrounding Broward County communities deal with year-round grass pollen, mold spores amplified by summer rainfall, and periodic particulate matter events that can trigger bronchoconstriction in sensitized airways.

For post-COVID patients whose airways are already primed for hyperresponsiveness, these environmental triggers can cause respiratory crises that appear unpredictable but are entirely traceable to local air quality patterns. Dr. Hull's practice incorporates local allergen surveillance and real-time air quality data into post-COVID asthma management plans for Broward County patients.

Getting Evaluated at Advanced Asthma Clinic

Advanced Asthma Clinic is located at 10059 NW 1st Court, Plantation, FL 33324 — centrally positioned to serve patients from throughout Broward County. We offer spirometry, FeNO measurement, methacholine challenge testing, and allergy evaluation under one roof. Most major insurance plans accepted. Call 954-522-7226 to schedule your post-COVID pulmonary evaluation.

When to Go to the Emergency Room

Seek Emergency Care Immediately If You Experience:

Severe shortness of breath at rest, inability to speak full sentences, bluish discoloration of lips or fingernails (cyanosis), silent chest (no wheeze despite struggling to breathe), peak flow below 50% of personal best, respiratory rate above 30 breaths per minute, confusion, or loss of consciousness. These signs suggest life-threatening bronchoconstriction, pulmonary embolism, cardiac decompensation, or acute respiratory failure. Call 911. Do not drive yourself.

Frequently Asked Questions — Post-COVID Asthma

Can COVID-19 cause asthma in someone who never had it before?

Yes. Research shows that approximately 13% of COVID-19 survivors develop new-onset asthma within 12 months of infection, compared to 5.5% of matched controls. SARS-CoV-2 causes direct bronchial epithelial injury, mast cell activation, and persistent airway hyperresponsiveness — all of which can trigger asthma in susceptible individuals who never had it before.

This is a recognized post-COVID complication and should be formally evaluated with lung function testing rather than treated empirically with inhalers without a confirmed diagnosis. Always consult your physician for personalized evaluation.

How long can COVID breathing problems last?

Long COVID respiratory symptoms — including shortness of breath, persistent cough, and chest tightness — can persist for months to years in some individuals. Studies show that 30–40% of COVID-19 survivors report breathing difficulties at 12 months post-infection.

In some cases, symptoms reflect structural airway changes; in others, they reflect deconditioning, dysfunctional breathing patterns, or PASC-related autonomic dysfunction. A pulmonologist can determine which mechanism is driving your symptoms and tailor treatment accordingly. Many patients improve significantly with targeted therapy even after prolonged symptom duration.

How do I know if my long COVID symptoms are actually asthma?

Asthma-specific features include: symptoms that vary day-to-day, worsen at night or early morning, respond to a bronchodilator (albuterol), or are triggered by exercise, cold air, allergens, or strong odors. These are important clues but cannot replace objective testing.

Spirometry showing reversible airflow obstruction (FEV1 improvement ≥12% and 200 mL after bronchodilator) confirms asthma. A methacholine challenge test identifies bronchial hyperresponsiveness when spirometry is normal. Elevated FeNO (≥25 ppb) strongly suggests eosinophilic airway inflammation. A pulmonologist can order and interpret all of these tests. Consult your physician for formal evaluation.

What is the difference between long COVID and asthma?

Long COVID (PASC) is a broad multi-system syndrome with over 200 reported symptoms. Respiratory long COVID can include dyspnea from deconditioning, dysfunctional breathing patterns, POTS (postural tachycardia syndrome), vocal cord dysfunction, or organizing pneumonia — as well as genuine new-onset asthma. These conditions require different treatments and must be distinguished carefully.

Asthma is specifically a chronic inflammatory airway disease characterized by bronchial hyperresponsiveness and variable airflow obstruction, confirmed on objective lung function testing. The two conditions can coexist. Proper evaluation separates these components and allows targeted treatment of each.

Can a COVID vaccine or booster trigger asthma symptoms?

Rarely. Some individuals with pre-existing asthma report transient worsening of symptoms in the 24–48 hours after COVID vaccination, which typically resolves spontaneously. Anaphylaxis — a severe immediate allergic reaction — can occur with any vaccine at approximately 2–5 cases per million doses; vaccination sites are equipped to manage this.

People with asthma, including severe asthma, are generally encouraged to receive COVID vaccines, as COVID-19 itself carries far greater risk of triggering a life-threatening asthma exacerbation than the vaccine does. Consult your physician before vaccination if you have specific concerns about your asthma history.

What treatments exist for post-COVID asthma?

Post-COVID asthma responds to standard asthma therapies: inhaled corticosteroids (ICS) are the cornerstone, combined with long-acting beta-agonists (LABA) when additional control is needed. For eosinophilic post-COVID asthma with elevated FeNO or blood eosinophils, biologic therapies — particularly dupilumab, which also addresses broader PASC Type 2 inflammation — can offer substantial benefit.

Associated PASC components require separate targeted treatment: breathing retraining for dysfunctional breathing, graded exercise rehabilitation for deconditioning, and speech therapy for vocal cord dysfunction. Consult your pulmonologist for a personalized, integrated management plan.

When should I see a pulmonologist for post-COVID breathing problems?

See a pulmonologist if: you still have shortness of breath, cough, or wheeze more than 4 weeks after COVID-19; your primary care physician has not been able to explain or relieve your symptoms; breathing limits your daily activity or exercise tolerance; you suspect asthma but have not had formal lung function testing; or you are using a rescue inhaler (albuterol) more than twice per week.

In Plantation, FL and greater Broward County, Dr. Frank Hull at Advanced Asthma Clinic specializes in post-COVID pulmonary evaluation. Early, accurate diagnosis prevents months of ineffective empirical treatment. Call 954-522-7226 to schedule.

Breathe Clearly Again After COVID-19

Dr. Frank Hull and the Advanced Asthma Clinic team offer comprehensive post-COVID respiratory evaluation — spirometry, FeNO, methacholine challenge, full PFTs — in Plantation, FL. Don't guess at your diagnosis. Get the answers your lungs deserve.

Call 954-522-7226 Request Appointment Online

Related Resources

Medical Disclaimer: This content is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult your physician or a qualified healthcare provider regarding any medical condition, including respiratory symptoms following COVID-19. Advanced Asthma Clinic, 10059 NW 1st Court, Plantation, FL 33324. Phone: 954-522-7226. Dr. Frank Hull, MD — Board-Certified Pulmonologist.